Compare companies
Put any US companies we track side by side — SEC-sourced financials, ratios, forensic scores, and our Quality Score. Add up to four. No market price, no paywall.
PERNIX THERAPEUTICS HOLDINGS, INC.
| Metric | PERNIX THERAPEUTICS HOLDINGS, INC. Healthcare |
|---|---|
| Quality Score | 24 / 100 |
| Revenue (latest) | $30M |
| Net income (latest) | −$29M |
| Operating margin | −67.6% |
| Net margin | −99.1% |
| Return on equity | 16.9% |
| Return on assets | −14.3% |
| Return on capital (ROCE) | −18.0% |
| Debt / equity | — |
| Revenue growth (YoY) | −8.4% |
| Altman Z″ (distress) | -8.05 |
| Accruals / assets | −11.4% |
Latest reported figures from each company's own SEC filings (XBRL) plus our derived scores. Blank where a line item isn't cleanly tagged — never estimated. Descriptive factors, not advice. Open a company for its full multi-year history.